Wilmington Savings Fund Society’s Alnylam Pharmaceuticals ALNY Stock Holding History

Wilmington Savings Fund Society’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$602	Buy	+2	New	+$603	﹤0.01%	1430
2025 Q3	–	Sell	-1,686	Closed	-$550K	–	1394
2025 Q2	$550K	Buy	1,686 +588	+54%	+$163K	0.01%	560
2025 Q1	$296K	Buy	1,098 +1,089	+12,100%	+$280K	0.01%	705
2024 Q4	$2.12K	Hold	9	–	–	﹤0.01%	1921
2024 Q3	$2.48K	Buy	+9	New	+$2.34K	﹤0.01%	1878

Other funds holding ALNY

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Wilmington Savings Fund Society's ALNY Position: Q2 2026 in Review

Wilmington Savings Fund Society opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 2 shares worth $602. The stake represents ﹤0.01% of the portfolio and ranks #1430 among its holdings. This is a return to the name: Wilmington Savings Fund Society previously reported a position in ALNY as recently as Q2 2025.

Wilmington Savings Fund Society first reported a position in ALNY in Q3 2024 and has held it in 5 quarters since. The position peaked at $550K in Q2 2025. 247 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Wilmington Savings Fund Society held 2 shares of Alnylam Pharmaceuticals worth $602 as of Q2 2026.
Alnylam Pharmaceuticals was a new Wilmington Savings Fund Society position in Q2 2026.
Alnylam Pharmaceuticals made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1430 holding.
Wilmington Savings Fund Society first reported a position in Alnylam Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
Wilmington Savings Fund Society's Alnylam Pharmaceuticals position peaked at $550K in Q2 2025.
247 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.